111 related articles for article (PubMed ID: 10953048)
61. Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord.
Cumberbatch MJ; Chizh BA; Headley PM
Br J Pharmacol; 1995 Jul; 115(6):1005-12. PubMed ID: 7582496
[TBL] [Abstract][Full Text] [Related]
62. Neurokinin receptors in the guinea pig ileum.
Nguyen-Le XK; Nguyen QT; Gobeil F; Jukic D; Chrétien L; Regoli D
Pharmacology; 1996 Jan; 52(1):35-45. PubMed ID: 8966201
[TBL] [Abstract][Full Text] [Related]
63. Selective agonists of tachykinin binding sites.
Lavielle S; Chassaing G; Loeuillet D; Convert O; Torrens Y; Beaujouan JC; Saffroy M; Petitet F; Bergström L; Glowinski J
Fundam Clin Pharmacol; 1990; 4(3):257-68. PubMed ID: 2165464
[TBL] [Abstract][Full Text] [Related]
64. Expression of neurokinin B/NK3 receptor and kisspeptin/KISS1 receptor in human granulosa cells.
García-Ortega J; Pinto FM; Fernández-Sánchez M; Prados N; Cejudo-Román A; Almeida TA; Hernández M; Romero M; Tena-Sempere M; Candenas L
Hum Reprod; 2014 Dec; 29(12):2736-46. PubMed ID: 25316443
[TBL] [Abstract][Full Text] [Related]
65. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
Tauer U; Zhao Y; Hunt SP; Culman J
Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
[TBL] [Abstract][Full Text] [Related]
66. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor.
Nguyen-Le XK; Nguyen QT; Gobeil F; Pheng LH; Emonds-Alt X; Brelière JC; Regoli D
Pharmacology; 1996 May; 52(5):283-91. PubMed ID: 8807672
[TBL] [Abstract][Full Text] [Related]
67. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
68. Pharmacophore and receptor models for neurokinin receptors.
Poulsen A; Bjørnholm B; Gundertofte K; Pogozheva ID; Liljefors T
J Comput Aided Mol Des; 2003 Nov; 17(11):765-83. PubMed ID: 15072436
[TBL] [Abstract][Full Text] [Related]
69. Kainic acid induced seizures cause a marked increase in the expression of neurokinin-3 receptor mRNA in the rat cerebellum.
Röder C; Bellmann R; McCarson KE; Krause JE; Sperk G
Neurosci Lett; 1994 Nov; 181(1-2):158-60. PubMed ID: 7898759
[TBL] [Abstract][Full Text] [Related]
70. Functional nonequivalence of structurally homologous domains of neurokinin-1 and neurokinin-2 type tachykinin receptors.
Blount P; Krause JE
J Biol Chem; 1993 Aug; 268(22):16388-95. PubMed ID: 8393861
[TBL] [Abstract][Full Text] [Related]
71. Monocyclic human tachykinin NK-2 receptor antagonists as evolution of a potent bicyclic antagonist: QSAR and site-directed mutagenesis studies.
Giolitti A; Altamura M; Bellucci F; Giannotti D; Meini S; Patacchini R; Rotondaro L; Zappitelli S; Maggi CA
J Med Chem; 2002 Aug; 45(16):3418-29. PubMed ID: 12139452
[TBL] [Abstract][Full Text] [Related]
72. Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends.
Graham A; Hopkins B; Powell SJ; Danks P; Briggs I
Biochem Biophys Res Commun; 1991 May; 177(1):8-16. PubMed ID: 1710456
[TBL] [Abstract][Full Text] [Related]
73. Characterization of a receptor for insect tachykinin-like peptide agonists by functional expression in a stable Drosophila Schneider 2 cell line.
Torfs H; Shariatmadari R; Guerrero F; Parmentier M; Poels J; Van Poyer W; Swinnen E; De Loof A; Akerman K; Vanden Broeck J
J Neurochem; 2000 May; 74(5):2182-9. PubMed ID: 10800964
[TBL] [Abstract][Full Text] [Related]
74. Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.
Giardina GA; Artico M; Cavagnera S; Cerri A; Consolandi E; Gagliardi S; Graziani D; Grugni M; Hay DW; Luttmann MA; Mena R; Raveglia LF; Rigolio R; Sarau HM; Schmidt DB; Zanoni G; Farina C
Farmaco; 1999 Jun; 54(6):364-74. PubMed ID: 10443017
[TBL] [Abstract][Full Text] [Related]
75. Endocytic recycling prevents copper accumulation in astrocytoma cells stimulated with copper-bound neurokinin B.
Menon R; Christofides K; Jones CE
Biochem Biophys Res Commun; 2020 Mar; 523(3):739-744. PubMed ID: 31952788
[TBL] [Abstract][Full Text] [Related]
76. Implication of possible therapies targeted for the tachykinergic system with the biology of neurokinin receptors and emerging related proteins.
Rameshwar P
Recent Pat CNS Drug Discov; 2007 Jan; 2(1):79-84. PubMed ID: 18221219
[TBL] [Abstract][Full Text] [Related]
77. Characteristics of Neurokinin-3 Receptor and Its Binding Sites by Mutational Analysis.
Atre I; Mizrahi N; Levavi-Sivan B
Biology (Basel); 2021 Sep; 10(10):. PubMed ID: 34681067
[TBL] [Abstract][Full Text] [Related]
78. Differential sensitivity to phenoxybenzamine alkylation among types of neurokinin binding sites.
Buck SH; Burcher E
Neuropeptides; 1987 Jan; 9(1):33-9. PubMed ID: 3561722
[TBL] [Abstract][Full Text] [Related]
79. Expression of Neurokinin B Receptor in the Gingival Squamous Cell Carcinoma Bone Microenvironment.
Yoshida S; Shimo T; Takabatake K; Murase Y; Obata K; Okui T; Kunisada Y; Ibaragi S; Nagatsuka H; Sasaki A
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34200131
[TBL] [Abstract][Full Text] [Related]
80. Isolation and characterisation of the human lung NK-1 receptor cDNA.
Hopkins B; Powell SJ; Danks P; Briggs I; Graham A
Biochem Biophys Res Commun; 1992 Feb; 182(3):1514. PubMed ID: 1311575
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
